Skip to main content
Premium Trial:

Request an Annual Quote

Ambry Genetics to Offer Fluidigm-Based Genomic Research Services


Ambry Genetics said today that it has launched genomic research services based on Fluidigm's BioMark HD and Access Array systems.

The services will include gene expression, SNP genotyping, and sample preparation for targeted sequencing using next-generation sequencers.

The BioMark HD System provides the sensitivity and throughput needed to study gene expression profiles down to the single-cell level, as well as high-throughput SNP genotyping and digital PCR for copy number variation and rare mutation detection.

Access Array enables high-throughput target enrichment for all of the major next-generation sequencing instruments, and allows users to simultaneously enrich multiple unique targets, such as exons, from a large number of samples, at low cost, Ambry said.

Fluidigm spokesperson Howard High told PCR Insider in an e-mail that besides Ambry, Fluidigm has other customers providing services with its products, but that Ambry's CLIA lab is "very successful and well-regarded."

High added that Ambry purchased both a BioMark HD and Access Array system, constituting "a good level of investment up front. Since [Ambry] has the ability to run some high-volume [research], then our follow-on chip and assay sales could be significant."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.